Your browser doesn't support javascript.
loading
Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials.
Bafadhel, Mona; Peterson, Stefan; De Blas, Miguel A; Calverley, Peter M; Rennard, Stephen I; Richter, Kai; Fagerås, Malin.
Afiliação
  • Bafadhel M; Respiratory Medicine Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK. Electronic address: mona.bafadhel@ndm.ox.ac.uk.
  • Peterson S; StatMind, Lund, Sweden.
  • De Blas MA; Global Medical Affairs, AstraZeneca, Cambridge, UK.
  • Calverley PM; School of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.
  • Rennard SI; Early Clinical Development, IMED Biotech Unit, AstraZeneca, Cambridge, UK; Department of Internal Medicine, Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
  • Richter K; Global Medical Affairs, AstraZeneca, Molndal, Sweden; Country Medical Director, AstraZeneca, Wedel, Germany.
  • Fagerås M; Global Medical Affairs, AstraZeneca, Molndal, Sweden.
Lancet Respir Med ; 6(2): 117-126, 2018 02.
Article em En | MEDLINE | ID: mdl-29331313

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Broncodilatadores / Budesonida / Doença Pulmonar Obstrutiva Crônica / Eosinófilos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Ano de publicação: 2018 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Broncodilatadores / Budesonida / Doença Pulmonar Obstrutiva Crônica / Eosinófilos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Ano de publicação: 2018 Tipo de documento: Article País de publicação: Reino Unido